Tianjin Ringpu Bio-Technology Co.,Ltd. Stock

Stocks

300119

CNE100000TV1

Pharmaceuticals

End-of-day quote 28/08/2026 5-day change 1st Jan Change
17.30 CNY +0.58% Intraday chart for Tianjin Ringpu Bio-Technology Co.,Ltd. -3.46% -7.83%

Valuation : Tianjin Ringpu Bio-Technology Co.,Ltd.

Market Cap 7.86B 1.17B 1.01B 943M 861M 1.62B 112B 1.63B 11.19B 4.37B 56.33B 4.38B 4.29B 187B P/E 2026 *
18x
P/E 2027 * 15.8x
Enterprise Value 8.37B 1.24B 1.07B 1.01B 918M 1.73B 119B 1.73B 11.93B 4.66B 60.05B 4.67B 4.57B 199B EV / Sales 2026 *
2.23x
EV / Sales 2027 * 1.94x
Free-Float
51.96%
Yield 2026 *
1.73%
Yield 2027 * 2.79%
08-25 Tianjin Ringpu Bio-Technology Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2026 CI
06-10 Tianjin Ringpu Bio-Technology Co.,Ltd. signed an Equity Transfer Agreement to acquire an additional 30% stake in Tianjin Zhongrui Supply Chain Management Co., Ltd. from Ringpai National Chain Veterinary Hospital Management Co., Ltd. for CNY 65.9 million. CI
04-27 Tianjin Ringpu Bio-Technology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
03-30 Tianjin Ringpu Bio-Technology Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025 CI
03-30 Tianjin Ringpu Bio-Technology Co.,Ltd. announces Annual dividend, payable on May 13, 2026 CI
03-27 Tianjin Ringpu Bio-Technology Co.,Ltd. announced that it expects to receive CNY 300 million in funding CI
11-28 Ringpu Bio-Technology Secures Registration For Feline Vaccine MT
30/10/25 Maxhealth Biotech Co. Ltd. announced that it has received CNY 400 million in funding from IDG Ventures, Shenzhen Capital Group Co., Ltd., Tianjin Ringpu Bio-Technology Co.,Ltd. CI
24/10/25 Tianjin Ringpu Bio-Technology Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2025 CI
25/08/25 Tianjin Ringpu Bio-Technology Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2025 CI
14/07/25 Ringpu Bio-Tech Forecasts Up to 70% Rise in H1 Profit MT
14/06/25 Jiangxi Twins Biotechnology Co., Ltd signed a letter of intent to acquire 67.18% stake in Hunan Sinoland Bio-Pharmacy Co., Ltd. from Tianjin Ringpu Bio-Technology Co.,Ltd. and Jingpeng Holding Group Co., Ltd for approximately CNY 115 million. CI
30/04/25 Tranche Update on Tianjin Ringpu Bio-Technology Co.,Ltd.'s Equity Buyback Plan announced on November 4, 2024. CI
1 day+0.58%
1 week-3.46%
Current month+1.65%
1 month+3.41%
3 months+7.19%
6 months-9.57%
Current year-7.83%
1 week 16.59
Extreme 16.59
17.62
1 month 16.59
Extreme 16.59
20.26
Current year 13.91
Extreme 13.91
21.51
1 year 13.91
Extreme 13.91
22.96
3 years 11.25
Extreme 11.25
28.9
5 years 11.25
Extreme 11.25
28.9
10 years 6.3
Extreme 6.3
44.41
Manager TitleAgeSince
Chief Executive Officer 53 30/03/2023
Director of Finance/CFO 51 28/04/2022
Corporate Officer/Principal 45 27/10/2020
Director TitleAgeSince
Chairman 63 12/05/2008
Director/Board Member 53 25/12/2019
Director/Board Member 51 10/01/2020
Date Insider Type Main position Quantity % Market Cap. Importance
5/24/23 A Buy 3,000 0.0009%
5/23/23 A Buy 1,000 0.0003%
9/4/20 A Sell

Chief Executive Officer

47,300 0.0193%
Change 5-day change 1-year change 3-year change Capi.($)
+0.58%-3.46%-22.84%-8.27% 1.17B
-0.59%-0.43%-49.74%-59.67% 31.96B
-0.87%-2.05%+34.01%+96.07% 12.05B
+2.32%+3.89%-16.64%+9.43% 4.04B
+0.15%-1.52%-2.85%+17.39% 3.15B
-0.63%+0.08%+48.77%+34.54% 2.05B
-1.40%-0.42%+11.32%+8.84% 1.97B
-0.49%+6.15%+2.17%+168.67% 1.53B
+1.62%+2.68%-9.46%-40.65% 1.05B
+0.14%-0.28%-6.02%-20.39% 947M
Average +0.08%+1.26%-1.13%+20.60% 5.99B
Weighted average by Cap. -0.36%+0.35%-19.58%-6.38%

Financials

2026 *2027 *
Net sales 3.75B 557M 480M 450M 411M 775M 53.28B 777M 5.34B 2.08B 26.89B 2.09B 2.05B 89.18B 4.22B 627M 540M 507M 462M 871M 59.93B 874M 6.01B 2.35B 30.25B 2.35B 2.3B 100B
Net income 427M 63.42M 54.65M 51.24M 46.77M 88.11M 6.06B 88.4M 608M 237M 3.06B 238M 233M 10.15B 508M 75.48M 65.04M 60.98M 55.67M 105M 7.21B 105M 723M 282M 3.64B 283M 277M 12.07B
Net Debt 519M 77.19M 66.52M 62.37M 56.93M 107M 7.38B 108M 740M 289M 3.72B 290M 284M 12.35B 337M 50.09M 43.16M 40.47M 36.94M 69.59M 4.79B 69.81M 480M 187M 2.42B 188M 184M 8.01B
Logo Tianjin Ringpu Bio-Technology Co.,Ltd.
Tianjin Ringpu Bio-Technology Co Ltd is a China-based company serving the animal health industry. The Company's main business areas are the research and development, production and sales of veterinary biological products, veterinary pharmaceutical preparations (chemicals, traditional Chinese veterinary medicines, disinfectants, and others), veterinary raw materials, veterinary functional additives, and provision of overall prevention and control of animal diseases. The Company's products include pharmaceuticals, vaccines, disinfectants, cleaning agents, and functional additives for pigs, chickens, waterfowl, cattle, sheep and pets, and others.
Employees
2,803
Date Price Change Volume
31/08/26 CN¥17.30 0.00% 5,255,897
28/08/26 CN¥17.30 +0.58% 4,256,797
27/08/26 CN¥17.20 +2.08% 5,548,290
26/08/26 CN¥16.85 -3.60% 7,605,800
25/08/26 CN¥17.48 +0.81% 4,272,386
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
4
Last Close Price
17.30CNY
Average target price
20.41CNY
Spread / Average Target
+17.98%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 300119 Stock